Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
Blalock 415
Baltimore, MD 21287Phone+1 410-614-0950
Education & Training
- Johns Hopkins Bloomberg School of Public HealthPh.D., Clinical Investigation, 2018 - 2023
- Johns Hopkins Bloomberg School of Public HealthCertificate, Public Health Economics, 2018 - 2021
- Johns Hopkins UniversityFellowship, Transplant Hepatology, 2014 - 2015
- Johns Hopkins UniversityFellowship, Gastroenterology, 2010 - 2013
- Duke University HospitalResidency, Internal Medicine, 2007 - 2010
- Emory University School of MedicineClass of 2007, M.D.
- Duke UniversityB.S., Biology, 1999 - 2003
- Duke UniversityA.B., Music, 1999 - 2003
Certifications & Licensure
- MD State Medical License 2013 - 2026
- NC State Medical License 2007 - 2010
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
- American Board of Preventive Medicine Addiction Medicine
Awards, Honors, & Recognition
- Membership Delta Omega Honorary Society in Public Health, 2023
- Clinical Research Leadership Program American College of Gastroenterology, 2023
- Outstanding Contribution Award Journal of Clinical and Translational Hepatology, 2019-2020
- Join now to see all
Clinical Trials
- Mitomycin C Therapy for Patients With Primary Sclerosing Cholangitis Start of enrollment: 2012 Sep 01
Roles: Contact
- Alcohol Treatment Outcomes Following Early vs. Standard Liver Transplant for SAH Start of enrollment: 2020 Nov 20
Publications & Presentations
PubMed
- 17 citationsInter-Hospital Escalation-of-Care Referrals for Severe Alcohol-Related Liver Disease with Recent Drinking During the COVID-19 Pandemic.Po-Hung Chen, Peng-Sheng Ting, Erik Almazan, Geetanjali Chander, Andrew M. Cameron
Alcohol and Alcoholism. 2021-07-05 - 121 citationsThree-year Results of a Pilot Program in Early Liver Transplantation for Severe Alcoholic HepatitisBrian Lee, Po-Hung Chen, Christine E. Haugen, Ruben Hernaez, Ahmet Gurakar
Annals of Surgery. 2017-01-01 - 109 citationsPrevalence of Perceived Dysphonia in a Geriatric PopulationJustin S. Golub, Po Hung Chen, Kristen J. Otto, Edie R. Hapner, Michael M. Johns
Journal of the American Geriatrics Society. 2006-11-01
Press Mentions
- During pandemic, hospitals see rise in alcohol-related liver diseaseJuly 17th, 2021
- 5 Surprising Things to Know About Fatty Liver DiseaseMay 6th, 2022
- The U.S.’s alcohol-induced death rate rose sharply in the pandemic’s first yearNovember 4th, 2022
- Join now to see all
Grant Support
- Project 2-Optimization of Post-Transplant care via Biomarkers and Behavioral InterventionsNational Institute on Alcohol Abuse and Alcoholism2019–2029
- Continuation of the Nonalcoholic Steatohepatitis Clinical Research Network (NASH CRN) Data Coordinating CenterNational Institute of Diabetes and Digestive and Kidney Diseases2022–2025
- Candidate Selection for Liver Transplantation in Patients with Alcohol-related Liver DiseaseNational Institute on Alcohol Abuse and Alcoholism2020–2025
- Development of an Interactive Bioethics Training Module for Healthcare ProvidersNational Institute on Alcohol Abuse and Alcoholism2023–2024
- The Impacts of Early Liver Transplantation and Sustained Abstinence on the Natural History of Severe Alcoholic Hepatitis – A Survival Benefit StudyGilead Sciences Research Scholars Program2019–2024
- Candidate Selection for Liver Transplantation in Patients with Alcohol-related Liver DiseaseJohns Hopkins University School of Medicine2020
- The Burden of Crohn’s Disease in Medicaid and Medicare PopulationsThe Helmsley Charitable Trust2019–2020
- Recurrence of non-alcoholic fatty liver disease after liver transplantation: incidence, risk factors, and implicationsJohns Hopkins Institute for Clinical and Translational Research / National Center for Advancing Translational Sciences2017–2019
- Estimating changes in liver fibrosis over time in patients with chronic viral hepatitis with transient elastography (i.e., FibroScan)Johns Hopkins Medicine / Kaiser Permanente Research Collaboration Committee2017–2018
- The role of moderate alcohol consumption in nonalcoholic fatty liver diseaseABMRF/The Foundation for Alcohol Research2013–2015
Committees
- Member, ACG Practice Parameters Committee 2024 - Present
- Member, ACG Lauren Gerson GRADE (Grading of Recommendations, Assessment, Development, and Evaluations) Program 2024 - Present
- Member, AASLD Practice Guidelines Committee 2022 - Present
- Member, ACG Research Committee 2023 - 2024
- Steering Committee, AASLD Alcohol-associated Liver Disease Special Interest Group 2021 - 2023
- Member, AASLD Continuing Medical Education Committee 2019 - 2021
Professional Memberships
- Fellow
- Member
- American Association for the Study of Liver Diseases - AASLDMember
- Research Society on Alcoholism - RSAMember
- Delta Omega Honorary Society in Public HealthMember
- International Liver Transplantation Society - ILTSMember
- Member
Other Languages
- Chinese (Mandarin), Taiwanese
External Links
- Johns Hopkins Medicinehttps://profiles.hopkinsmedicine.org/provider/Victor+Chen/2703694
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: